CohBar — Company Overview, News & Financial Data

CohBar (NASDAQ:CWBR) is a biotechnology company focused on the research and development of mitochondria-based therapeutics (MBTs), an innovative class of drugs intended to treat diseases associated with aging and metabolic dysfunction. The company's pipeline includes projects aimed at tackling a wide range of conditions, including obesity, type 2 diabetes, cancer, and cardiovascular diseases, by leveraging the therapeutic potential of mitochondrial-derived peptides (MDPs). With a mission to extend healthy lifespan and improve the quality of life, CohBar's ongoing research and development activities underscore its commitment to pioneering the exploration of mitochondria's role in health and disease.